Marksans Pharma Share Price Target 2025, 2030, 2040, 2050

Marksans Pharma Ltd is an Indian company that makes and sells medicines in different countries. They have branches in the UK and the US, and they sell their medicines in many countries.

What is Marksans Pharma Ltd NSE: MARKSANS?

Marksans Pharma Ltd is a company that makes and sells medicines. They make medicine for heart problems, brain and nerve conditions, diabetes, pain, cancer, infections and more. Besides these, they provide prescription medicines for heart and nerve health, cancer, diabetes, and infections.

 They are not only limited to India to sell its products but also supply it to different countries. They have multiple branches in the outside of the country. Most of their income comes from the United States and North America.

Marksans Pharma Share Price Target 2025

This company is growing its business in India and many other countries. They are also starting to work with big drug companies in the US and Europe to make and sell different medicines. Their main goal is to become strong in the US market for generic drugs. They are also looking into new markets. In 2025, its share price target would be ₹383, as per our analysis.
By our prediction, its share price would be between ₹138 to ₹383 in 2025.

Year	Minimum Price	Maximum Price
2025	138	383

Month	Minimum Price	Maximum Price
January	217	308
February	201	276
March	181	278
April	168	280
May	152	283
June	144	285
July	138	290
August	168	318
September	187	348
October	258	355
November	269	368
December	290	383

Marksans Pharma Share Price Target 2030

The company is expanding its range of generic drugs and antibiotics to keep up with growing customer needs. companies have been able to produce affordable generic drugs to meet increasing demand. The company is growing its production and will benefit the Indian medicine drug market. Also, it always focused on Research & Development to create and improve new products. So in 2030, the price target would be 1600 rs.

Year	Minimum Price	Maximum Price
2030	1200	1600

Month	Minimum Price	Maximum Price
January	1200	1320
February	1215	1300
March	1225	1328
April	1232	1350
May	1260	1390
June	1280	1410
July	1350	1470
August	1466	1500
September	1470	1510
October	1490	1540
November	1520	1570
December	1560	1600

Share Price Target 2040

The company makes medicines for the major disease. It always has good quality with better pricing. It is always spent on research to do better. Also, the company expands its business by including small companies to own companies. This will make it a big company and there will be fewer competitors in the market. So, we could expect 3620 rs as the price target in 2040.

Year	Minimum Price	Maximum Price
2040	2800	3620

Month	Minimum Price	Maximum Price
January	2800	2920
February	2850	2900
March	3000	3200
April	3120	3340
May	3200	3400
June	3270	3430
July	3300	3440
August	3390	3460
September	3400	3500
October	3480	3520
November	3520	3600
December	3570	3620

Share Price Target 2050

The company is developing new products each year to help its business grow, and this should lead to significant growth in the future. The Indian government is also helping local manufacturers with different programs. This company is increasing its production quickly to take advantage of this support, which will help its business grow even faster. The company had great brand value outside the country too. It had many branches in different parts of the world, so it had a bright feature. in 2050, the price target would be 6000 rs.

Year	Minimum Price	Maximum Price
2050	4900	6000

Month	Minimum Price	Maximum Price
January	4900	5100
February	4960	5180
March	4990	5200
April	5000	5190
May	5060	5200
June	5100	5330
July	5200	5410
August	5380	5500
September	5400	5660
October	5540	5790
November	5700	5870
December	5840	6000

Should I Buy Marksans Pharma Stock?

Year	Minimum Price	Maximum Price
2024	138	383
2025	240	430
2030	1200	1600
2040	2800	3620
2050	4900	6000

The company has top competitors in the pharmaceutical industry. Every year they spend much money to do research to do better. They are very well-known outside the country too. The company has good potential to grow in the future. So, If you’re planning to invest for the long term and want to take advantage of this growth, then you can take a risk in this stock.

Marksans Pharma Ltd Earning Results

Market Capital	8,578.39 Crore
Revenue (TTM)	2,177.4 Crore
Net Income (TTM)	+313.69 Crore
Operating Margin	15.81%
Profit Margin	14.4%
Revenue Growth (Quarterly)	+15.2%
Earnings Growth (YOY Quarterly)	-5.3%
Debt-to-Equity (D/E) Ratio	11.7
Total Debt	244.06 Crore
Total Cash	700.57 Crore
Beta	1.65

Is Marksans Pharma Stock Good to Buy? (Bull case & Bear case)

Bull Case:

• India is becoming a big player in the pharmaceutical industry, and Marksans Pharma could benefit from this.
• The company is adding new products and increasing its production, which might lead to more growth.
• Marksans Pharma is getting support from government programs for local businesses.
• This company spread not only within India but also had branches in different parts of the world.

Bear Case:

• There’s a lot of competition in the industry, which could impact the company.
• The pharmaceutical industry can be unpredictable, and there might be challenges.

Conclusion

So, we have discussed in depth about this stock. This company is very old it was established in 1992. It had a great business in India and outside of the country too. The company plans to include the small company in its own sector to grow the company. Also, it spends money on research and development for a better future.

FAQs